Ultrasound-Guided Breast Biopsy Market Outlook (2022 to 2032)

The global ultrasound-guided breast biopsy market is expected to reach USD 1,090 Million in 2032, exhibiting a CAGR of 8% during the forecast period. Ultrasound-guided biopsy market is currently valued at USD 720 Million in 2022.

Rising incidence of breast cancer cases and increasing awareness about early diagnosis of breast cancer will push sales in the market over the forecast period.

Report Attribute Details
Ultrasound-Guided Breast Biopsy Market Size (2022) USD 720 million
Ultrasound-Guided Breast Biopsy Market Size (2032) USD 1,090 million
Ultrasound-Guided Breast Biopsy Market Projected Growth Rate (2022 to 2032) 8% CAGR

According to a 2021 report by WHO, there were 2.3 million women diagnosed with breast cancer and 685,000 deaths, globally, in the year 2020. In 2020, 7.8 million women were living with breast cancer, making it world’s most prevalent cancer.

Breast cancer forms either with the breast tissue which is made up of glands for milk production known as lobules or begins in the ducts. These abnormalities or lumps in the breasts are generally detected with mammography, physical examinations, or other imaging techniques such as ultrasound-guided breast biopsy.

In an ultrasound-guided breast biopsy, radiologists use ultrasound imaging as a guide to inspect the site of the abnormal cell growth. A breast biopsy with the aid of ultrasound is mostly performed when an abnormality such as a distortion of the breast tissue or a suspicious mass of solid is felt around the breast.

High rate of mortality and increasing incidence of breast cancer will underpin the adoption of ultrasound-guided breast biopsy over the assessment period.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Which are Factors Spurring Demand in the Ultrasound-Guided Breast Biopsy Market?

Ultrasound-guided breast biopsy is comparatively less invasive than other surgical biopsies, it leaves little scarring and can be performed in a limited time frame. These factors, combined together, will increase the adoption rate of ultrasound-guided breast biopsy.

In addition to this, ultrasound-guided breast biopsy does not carry ionizing radiation and provides faster results. It is also less expensive and has shorter recovery period. On the back of these factors, demand in the market is projected to increase at a considerable pace over the forecast period.

Which are Factors Hindering the Growth in the Ultrasound-Guided Breast Biopsy Market?

Ultrasound-guided breast biopsy also has certain aspects that impede sales in the market. The ultrasound-guided breast biopsy is known to carry a risk of bleeding that forms hematoma because of which consumers might reject this method of biopsy. This in turn hampers the growth in the ultrasound-guided breast biopsy market.

Furthermore, other factors such as discomfort experienced by patients during biopsy and the cost of an ultrasound machine might also impede the growth in ultrasound-guided breast biopsy market over the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What is the Demand Outlook of the Ultrasound-Guided Breast Biopsy Market in North America?

The American Cancer Society’s estimates for the year 2022 states that there will be 287,850 new cases of breast cancer, with 43,250 deaths. This rising prevalence of breast cancer along with an increasingly alert population may increase the demand for ultrasound-guided breast biopsy in North America.

Thus, ultrasound-guided breast biopsy market in North America is expected to exhibit a significant growth rate for the forecast period. Advancing technologies, high investments in the healthcare sector, and increasing production of new and improved imaging technologies will augment sales in the ultrasound-guided breast biopsy market in North America.

How is Surging Awareness Of Breast Cancer Propelling Sales of Ultrasound-Guided Breast Biopsy in Asia Pacific?

Increasing awareness regarding early diagnosis and treatment of breast cancer among individuals across Asia Pacific is expected to create opportunities for growth in the market. Owing to rising amount of campaigns about breast cancer, majority of the population is aware about diagnosis and treatment methods for breast cancer. This is expected to boost the Asia Pacific ultrasound-guided breast biopsy market over the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Market Competition

Leading players operating in the global ultrasound-guided breast biopsy market include Hologic, Inc., Medsurge Ind Private Limited among others.

Key companies in the market are engaged in developing their portfolio of breast biopsy products and accessories. The focus is also on contracts and partnerships to launch insight driven products, product commercialization and pipeline development in order to strengthen market position.

Report Scope

Report Attribute Details
Growth Rate CAGR of 8% from 2022 to 2032
Base Year for Estimation 2021
Historical Data 2015 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered

Procedure, End User, Region

Countries Covered

North America (USA, Canada), Latin America (Mexico, Brazil), Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg), Eastern Europe (Russia, Poland), Asia-Pacific Excluding Japan(China, India, ASEAN, Australia & New Zealand), Japan, Middle East and Africa (GCC Countries, South Africa, North Africa)

Key Companies Profiled Hologic Inc; Medsurge Ind Private Limited
Customization Available Upon Request

Key Segments Profiled in the Ultrasound-Guided Breast Biopsy Market Survey

By Procedure:

  • Fine needle aspiration (FNA) ultrasound-guided breast biopsy
  • Core needle (CN) ultrasound-guided breast biopsy
  • Vacuum-assisted device (VAD) ultrasound-guided breast biopsy
  • Wire localization ultrasound-guided breast biopsy

By End User:

  • Hospitals
  • Clinics
  • Diagnostics Laboratories
  • Others

By Region:

  • North America (USA, Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Russia, Poland)
  • Asia-Pacific Excluding Japan(China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, North Africa)

Frequently Asked Questions

Which region is set to lead the ultrasound-guided breast biopsy market growth?

North America is set to lead ultrasound-guided breast biopsy market growth over the forecast period.

Which are the major players in the ultrasound-guided breast biopsy market?

Hologic Inc. and Medsurge Ind Private Limited are the two key players in the ultrasound-guided breast biopsy market.

What is the estimated value of ultrasound-guided breast biopsy market for 2022?

The global ultrasound-guided breast biopsy market is estimated to reach USD 720 Million in 2022.

Table of Content
	1. Executive Summary
	2. Market Overview
	3. Market Background
	4. Global Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
	5. Global Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Procedure
		5.1. Fine Needle Aspiration (FNA)
		5.2. Core Needle (CN)
		5.3. Vacuum to assisted Device (VAD)
		5.4. Wire Localization
	6. Global Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
		6.1. Hospitals
		6.2. Clinics
		6.3. Diagnostics Laboratories
		6.4. Others
	7. Global Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
		7.1. North America
		7.2. Latin America
		7.3. Europe
		7.4. Asia Pacific
		7.5. Middle East and Africa
	8. North America Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
	9. Latin America Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
	10. Europe Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
	11. Asia Pacific Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
	12. Middle East and Africa Ultrasound to Guided Breast Biopsy Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
	13. Key Countries Ultrasound to Guided Breast Biopsy Market Analysis
	14. Market Structure Analysis
	15. Competition Analysis
		15.1. Hologic
		15.2. Medsurge
		15.3. Ethicon Endo Surgery
		15.4. Galini
		15.5. Leica Biosystems
		15.6. Becton and Dickinson Company
		15.7. Cook Medical Incorporated
		15.8. Argon Medical Devices
	16. Assumptions & Acronyms Used
	17. Research Methodology
Recommendations

Healthcare

Automated Breast Ultrasound Systems Market

June 2023

REP-GB-606

315 pages

Healthcare

Aspiration & Biopsy Needles Market

April 2023

REP-GB-14287

333 pages

Healthcare

Breast Biopsy Devices Market

October 2022

REP-GB-1496

353 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Ultrasound-Guided Breast Biopsy Market

Schedule a Call